Christian Weyer, M.D., M.A.S
2013 - Fate Therapeutics
In 2013, Christian Weyer, M.D., M.A.S earned a total compensation of $503.1K as President, Chief Executive Officer and Director at Fate Therapeutics, a 33% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $153,125 |
---|---|
Salary | $350,000 |
Total | $503,125 |
MAS received $350K in salary, accounting for 70% of the total pay in 2013.
MAS also received $153.1K in non-equity incentive plan.
Rankings
In 2013, Christian Weyer, M.D., M.A.S' compensation ranked 9,335th out of 12,286 executives tracked by ExecPay. In other words, MAS earned more than 24.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,335 out of 12,286 | 24th |
Division Manufacturing | 3,426 out of 4,612 | 26th |
Major group Chemicals And Allied Products | 1,085 out of 1,462 | 26th |
Industry group Drugs | 835 out of 1,156 | 28th |
Industry Biological Products, Except Diagnostic Substances | 140 out of 196 | 29th |
Source: SEC filing on April 2, 2015.
MAS' colleagues
We found two more compensation records of executives who worked with Christian Weyer, M.D., M.A.S at Fate Therapeutics in 2013.